With chelation therapy as one of my main treatment modalities, I necessarily also frequently prescribe nutritional supplements. One reason being for example, that without re-mineralization of the body after a series of drips, chelation does not really work. I also come across a good number of heart patients, and in many cases I give them C-Enzyme Q10 to help strengthening their heart function. Why, the following excerpt from the ENCYCLOPEDIA OF NUTRITIONAL SUPPLEMENTS will amply explain.“An important yet frequently overlooked component in the overall treatment of cardiovascular disease is the promotion of a better functioning heart. Degenerative lesions in the heart are found in most types of cardiovascular disease, including angina, high blood pressure, and congestive heart failure. They result from repeated insults to the heart such as low oxygen supply, inflammation, and other factors. CoQ10 can reverse or prevent the degenerative lesions of the heart associated with these diseases and enhance the mechanical function of a failing heart. It does so by providing optimal nutrition at the cellular level.”
“The potential therapeutic use of CoQ10 in cardiovascular disease has been clearly documented in both animal studies and human trials. CoQ10 deficiency is common in cardiac patients. Biopsy results from heart tissue in patients with various cardiovascular diseases showed a CoQ10 deficiency in 50% to 75% of the cases (for example according to research for published by Kitamra, N.; Folkers K.; Littaru, GP.; Ho, L.; Vadhanavikit, S.; and Mortensen, SA. in Proceeds of the Natural Academy of Science and other publications). Correcting a CoQ10 deficiency can produce dramatic clinical results.”
“To highlight the effectiveness of CoQ10 for a wide variety of cardiovascular disease let’s examine the results from a clinical cardiology unit that utilized CoQ10 in 424 patients over an 8-year period (1985-1993). Doses of CoQ10 ranged from 75 to 600 milligrams per day by mouth (average 242 milligrams). Treatment was guided primarily by the patients’ clinical response.” In many instances, CoQ10 levels were employed with the aim of producing a whole blood level greater than or equal to 2.10 micrograms per milliliter.”
“Patients were followed for an average of 17.8 months, with a total accumulation of 632 patient years. Eleven patients were omitted from the study, ten because of noncompliance and one who experienced nausea...” Patients were divided into six diagnostic categories:
- Ischemic Cardiomyopathy
- Dilated Cardiomyopathy
- Primary Diastolic Dysfunction
- High Blood Pressure
- Mitral Valve Prolapse
- Heart Valve Disorders
“For the entire group and for each diagnostic category, clinical response was evaluated according to the New York Heart Association (NYHA) functional scale. Of 424 patients, 58% improved by one NYHA class, 28% by two classes, 1.2% by three classes. A statistically significant improvement in heart function was documented using the following echo-cardiographic parameters: left ventricular wall thickness; mitral valve inflow slope, and fractional shortening. “
“Before treatment with CoQ10, most patients were taking from one to five cardiac medications. During the study, overall medication requirements dropped considerably – 43% of the patients stopped between one and three drugs. Only 6% of the patients required the addition of one drug. No apparent side effects were noted other than a single case of transitional nausea.”
The cardiologists concluded, ‘CoQ10 is a safe and effective adjunctive treatment for a broad range of cardiovascular diseases, producing gratifying clinical responses while easing the medical and financial burden of multi-drug therapy.’”